Loading
Biomerieux Stock: price and insider trades · France
9 insiders bought shares over the last 90 days, the latest by Francois Lacoste, filed 03 Sept 2026.
Insider Decl.
89
Thresholds
n/a
Buy Volume
€165M
35 ops. · all time
Sell Volume
€135M
25 ops. · all time
Who traded when
BuySaleHarold Boël4 sales
Jennifer Zinn2 buys2 sales
Celine Martin Roger Dalbert1 buy2 sales
Yasha Mitrotti Ventura1 buy2 sales
Alexandre Mérieux2 buys
Guillaume Bouhours1 buy1 sale
+6 other insiders
Since the insiders bought
- +18.9%Entry €72.55 · Close 21 Oct 2026 €86.25
- +16.2%Entry €74.25 · Close 21 Oct 2026 €86.25
- +16.2%Entry €74.25 · Close 21 Oct 2026 €86.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Biomerieux Hold (neutral), based on 14 analysts. Average price target: €79.90.
Fundamental score
Ranked 6,847 of 26,250 companies
63.6
score / 100
Value54
Quality73
FCF yld4.5%
Earn yld3.9%
EV/EBITDA12.5x
ROE11%
Gross mgn57%
Net mgn9.8%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€86.25
Analyst consensus
14 analystsHold
€71.00Target €79.90(-7%)€100.00
Income statement
Revenue€4.1B
Gross profit€2.3B57% margin
EBITDA€848.6M21% margin
Net income€397.5M11.6% margin
Valuation
PER (trailing)21.9x
PER (forward)18.5x
P/Book2.4x
Beta0.55
Balance sheet & cash
Market cap€10.2B
Total debt€461.4M
Free Cash Flow€453.1M
Debt / Equity10%
Profitability & ownership
ROE11.2%
ROA7.2%
% insiders66.5%
% institutions15.5%
Last declaration on 3 September 2026
Declarations89 total
4,203 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1136012
Canonical exit: 29 Nov 2026 (T+90)
2,375 shares@ €74.93040.0017% mcap22.4% of flowactions gratuitesEuronext ParisISIN FR00132802862026DD1135785-T2
4,903 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135785
Canonical exit: 29 Nov 2026 (T+90)
5,137 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135768
Canonical exit: 29 Nov 2026 (T+90)
1,404 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135743
Canonical exit: 29 Nov 2026 (T+90)
503 shares@ €74.93040.0004% mcap18.1% of flowActions gratuitesEuronext ParisISIN FR00132802862026DD1135743-T2
1,026 shares@ €74.93040.0008% mcap24.7% of flowActions gratuitesEuronext ParisISIN FR00132802862026DD1135780-T2
2,491 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135780
Canonical exit: 29 Nov 2026 (T+90)
7,588 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135781
Canonical exit: 29 Nov 2026 (T+90)
3,123 shares@ €74.93040.0023% mcap75.3% of flowactions gratuitesEuronext ParisISIN FR00132802862026DD1135781-T2
3,502 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135724
Canonical exit: 29 Nov 2026 (T+90)
5,020 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135727
Canonical exit: 29 Nov 2026 (T+90)
3,852 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135731
Canonical exit: 29 Nov 2026 (T+90)
10,741 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135735
Canonical exit: 29 Nov 2026 (T+90)
277,058 shares@ €118.45520.37% mcap100.0% of flowActionEuronext ParisISIN FR00132802862026DD1123840
248,633 shares@ €119.729323.0% of flowActionEuronext ParisISIN FR00132802862026DD1123840-T2
24,309 shares@ €121.52822.3% of flowActionEuronext ParisISIN FR00132802862026DD1123840-T3
550,000 shares@ €116.5049.4% of flowActionHors plateforme de négociationISIN FR00132802862026DD1123840-T4
404,367 shares@ €71.9640.34% mcap0.4% of flowActionMultiplacesISIN FR00132802862026DD1112471
Canonical exit: 2 Aug 2026 (T+90)
779,245 shares@ €69.99720.64% mcap0.8% of flowActionMultiplacesISIN FR00132802862026DD1112475
Canonical exit: 29 Jul 2026 (T+90)
2,299 shares@ €114.535642.8% of flowActions gratuitesEuronext ParisISIN FR00132802862025DD1057334
1,486 shares@ €114.5356100.0% of flowActions gratuitesEuronext ParisISIN FR00132802862025DD1057335
4,625 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862025DD1057274
3,677 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862025DD1057289
7,875 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862025DD1056992
25 of 89 declarations
About Biomerieux
On October 4, 2024, Alexandre Merieux, chairman of the board of Biomerieux, filed a purchase of EUR 81,002,490, the largest in the record. The same chairman, spelled Alexandre Mérieux, filed EUR 54,544,968 on April 30, 2026 and EUR 29,099,867 on May 4, 2026. Of 35 purchases, 11 carry an amount, EUR 164,845,803 in total (median EUR 31,831), which makes 69% of open-market trades, against 16 sales worth EUR 36,753,216 (median EUR 160,341).
The largest sale, EUR 32,818,961, is Harold Boël's, a director, on July 1, 2026. Pierre Charbonnier (Directeur Exécutif Qualité Globale, Manufacturing & Supply Chain) filed EUR 1,650,416 on March 23, 2023, and Pierre BOULUD (Directeur Général) EUR 673,419 on March 10, 2025.
Read moreShow less
The healthcare group is valued at EUR 10.2 billion, with 66.5% held by insiders and 20 filers. On August 31, 2026, 9 filers filed on the same day. Across the full history, 4 purchase filings are classed as clustered. Of 80 filings since 2021, 21 are grants. Yasha Mitrotti Ventura (Executive Vice President Industrial Applications) has 9, Guillaume Bouhours 8 and Pierre BOULUD 8. The 13 filings of the last twelve months include 12 purchases and 1 sale. The median publication delay is 3 days. For 25 purchases a 90-day result is stored: a median of 1.2%, with 64% of cases positive; recorded past results, not a forecast.
